Saccharomyces cerevisiae-derived HBsAg preparations differ in their attachment to monocytes, immune-suppressive potential, and T-cell immunogenicity

Journal of Medical Virology

Volumn 70, Issue 4, 2003, Pages 513-519

  Vanlandschoot, Peter ^a   Van Houtte, Freya ^a   Hoek, Frans ^b   Nieuwland, Rienk ^b   Leroux Roels, Geert ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

CD14; Lipopolysaccharide; Lipopolysaccharide binding protein; Phospholipid; RHBsAg

Indexed keywords

CD14 ANTIGEN; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 2; LIPID BINDING PROTEIN; LIPOPOLYSACCHARIDE; LIPOPROTEIN; PHOSPHOLIPID; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN BINDING; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL INTERACTION; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOGENICITY; MONOCYTE; NONHUMAN; PROTEIN EXPRESSION; SACCHAROMYCES CEREVISIAE; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD14; CRICETINAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOSUPPRESSION; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MONOCYTES; PHOSPHOLIPIDS; RECOMBINANT PROTEINS; SACCHAROMYCES CEREVISIAE; T-LYMPHOCYTES;

HEPATITIS B VIRUS; SACCHAROMYCES CEREVISIAE;

EID: 0037708320     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.10425     Document Type: Article

References (13)

1. Bligh EG, Dyer WJ. 1959. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 235:911-917.
2. Diminsky D, Schrimbeck R, Reimann J, Barenholz Y. 1997. Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansuela polymorpha): composition, structure and immunogenicity. Vaccine 15:637-647.
3. Gavilanes F, Gonzales-Ros JM, Peterson DL. 1982. Structure of hepatitis B surface antigen. Characterization of the lipid components and their association with the viral proteins. J Biol Chem 257:7770-7777.
4. Jack RS, Grunwald U, Stelter F, Workalemahu G, Schutt C. 1995. Both membrane-bound and soluble forms of CD14 bind to gram-negative bacteria. Eur J Biochem 25:1436-1441.
5. Leroux-Roels G, Cao T, De Knibber A, Meuleman P, Roobrouck A, Farhoudi A, Vanlandschoot P, Desombere I. 2001. Prevention of hepatitis B infections: vaccination and its limitation. Acta Clin Belg 56:209-219.
6. Seeger C, Mason WS. 2000. Hepatitis B virus biology. Microbiol Mol Biol Rev 64:51-68.
7. Stelter F, Bernheiden M, Menzel R, Jack RS, Witt S, Fan X, Pfister M, Schutt C. 1997. Mutation of amino acids 39-44 of human CD14 abrogates binding of lipopolysaccharide and Escherichia coli. Eur J Biochem 243:100-109.
8. Stelter F, Loppnow H, Menzel R, Grunwald U, Bernheiden M, Jack RS, Ulmer AJ, Schutt C. 1999. Differential impact of substitution of amino acids 9-13 and 91-101 of human CD14 on soluble CD14-dependent activation of cells by lipopolysaccharide. J Immunol 163:6035-6044.
9. Van der Meeren P, Van Criekinge W, Vanderdeelen J, Baert L. 1994. Phospholipid composition of r-DNA hepatitis B surface antigens. Int J Pharm 106:89-92.
10. Vanlandschoot P, Van Houtte F, Roobrouck A, Farhoudi A, Leroux-Roels G. 2002a. Yeast derived hepatitis B surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor. J Gen Virol 83:1281-1289.
11. Vanlandschoot P, Van Houtte F, Roobrouck A, Farhoudi A, Stelter F, Peterson DL, Gomez-Gutierrez J, Gavilanes F, Leroux-Roels G. 2002b. LPS binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles. J Gen Virol 83:2279-2289.
12. Vanlandschoot P, Roobrouck A, Van Houtte F, Leroux-Roels G. 2002c. Recombinant HBsAg, an apoptotic-like lipoprotein, interferes with the LPS-induced phosphorylation of ERK-1/2 and JNK-1/2 in monocytes. Biochem Biophys Res Commun 297:486-491.
13. Weerheim AM, Kolb AM, Sturk A, Nieuwland R. 2002. Phospholipid composition of cell-derived microparticles determined by one-dimensional high-performance thin-layer chromatography. Anal Biochem 302:191-198.